Roughly half of the U.S. population gets health coverage through some form of government-sponsored insurance. And with control of both...

Health system leaders have long been interested in figuring out ways to monetize clinical data. It makes sense: if they could sell or license de-identified data in their EHRs to life science or tech companies, that would be very helpful from a revenue diversification perspective. Especially whenever core inpatient economics are under siege. But, it’s always been an easier-said-than-done proposition. And now, maybe there's also a new spoiler in the mix, in the form of 'synthe

Later this week, we'll be convening live for this month's Board Briefing webinar to talk about the current state of the physician...

If you’ve seen our State of Healthcare presentation, you’ll know that despite provider margins seemingly rebounding at the top line, it’s...

Time to separate the settled from the volatile issues in risk/VBC politics today With so much policy upheaval these days, it can be easy...

If your go-to mental model for risk/VBC revolves around primary care management of chronic conditions, it's time for a conceptual...

Last week, we published an update on the Make America Healthy Again initiative: what its agenda looks like as of April 2025 and how the...

Back in December, we conducted something of a thought experiment. At the time, then-nominee Robert F. Kennedy, Jr.'s "Make America...

At the beginning of each year, we like to do a deep dive into the healthcare investment landscape. We do a retrospective on the previous...

This month's Union Strategy Bootcamp, “How to Speak Ambulatory" is set to cover all the essentials : Key concepts, players,...

Today's post is the fifth in an ongoing series we're publishing on key players in healthcare vertical consolidation . Nearly everyone in...

Today's post is the fourth in an ongoing series we're publishing on key players in healthcare vertical consolidation . Nearly everyone in...